Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

NCT03043599 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer
Extensive-stage Small Cell Lung Cancer

Interventions

RADIATION: Thoracic Radiation Therapy
DRUG: Ipilimumab
DRUG: Nivolumab

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]